Aligos Therapeutics received a notification letter from Nasdaq regarding noncompliance with listing rule for minimum number of independent directors on the Audit Committee.
AI Assistant
ALIGOS THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.